65 results
8-K
EX-10.1
VANI
Vivani Medical Inc
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(mm) U.S. Real Property Holding Corporation. The Company
8-K
VANI
Vivani Medical Inc
10 Jan 24
Other Events
4:30pm
, Vivani Medical, Inc. (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq
8-K
9nc8qf0jz21x
27 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
DEFR14A
01ewv
1 May 23
Revised proxy
4:49pm
8-K
EX-10.1
tzk66553qao
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm
8-K
s7z9y0uuq
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
425
EX-99.1
kuu2u8wssw6ncnk
29 Jul 22
Business combination disclosure
9:07am
8-K
EX-99.1
arz 5j9xvfkyat
29 Jul 22
Submission of Matters to a Vote of Security Holders
9:05am
DEFA14A
64nrhp
18 Jul 22
Additional proxy soliciting materials
8:47am
425
EX-99.1
tgyzq52gu6xj
18 Jul 22
Business combination disclosure
8:45am
8-K
EX-99.1
xmius
18 Jul 22
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
8:44am
DEFM14A
bbq031jl6nfm9rye06i6
24 Jun 22
Proxy related to merger
4:44pm
424B3
qdhbs
24 Jun 22
Prospectus supplement
4:38pm
425
6woqdaw1
21 Jun 22
Business combination disclosure
4:03pm